This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Armin Kern: Innovator in Oligopeptide Antibiotics
Introduction
Armin Kern is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of oligopeptide antibiotics. His work has implications for medical science, especially in combating fungal infections.
Latest Patents
Kern holds a patent for oligopeptide antibiotics known as Rhizocticines. The formula involves specific amino acid configurations, where X represents hydrogen or a hydrophobic amino acid radical, and Y represents a basic amino acid radical. The C2 atoms of the amino acid radicals are in the L-configuration, along with protected derivatives and salts. These compounds are derived from culture broths of Bacillus subtilis or can be synthesized, showcasing their fungicidal action.
Career Highlights
Armin Kern has been associated with Ciba-Geigy Corporation, a company known for its innovative contributions to pharmaceuticals and agrochemicals. His work at the corporation has allowed him to explore and develop new antibiotic compounds that can potentially revolutionize treatment options.
Collaborations
Kern has collaborated with notable colleagues such as Martin Kugler and Gunther Jung. Their combined expertise has contributed to advancements in the field of antibiotic research and development.
Conclusion
Armin Kern's innovative work in the development of oligopeptide antibiotics highlights his significant role in the scientific community. His contributions continue to influence the field of biochemistry and medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile